BEXACAT DIN 02562936
Health Canada record
| Active ingredient(s) | BEXAGLIFLOZIN 15 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 13-Aug-2026 |
| Current status date | 13-Aug-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2026-09-21).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36398 | 2025-11-19 | New Drug Submission (NDS) |
International API supply for BEXAGLIFLOZIN
1 active FDA Drug Master Files.
Request a quote for BEXACAT